203 related articles for article (PubMed ID: 27765918)
1. β-catenin interaction with NHERF1 and RASSF1A methylation in metastatic colorectal cancer patients.
Schirosi L; Mazzotta A; Opinto G; Pinto R; Graziano G; Tommasi S; Fucci L; Simone G; Mangia A
Oncotarget; 2016 Oct; 7(42):67841-67850. PubMed ID: 27765918
[TBL] [Abstract][Full Text] [Related]
2. NHERF1/EBP50 is a new marker in colorectal cancer.
Hayashi Y; Molina JR; Hamilton SR; Georgescu MM
Neoplasia; 2010 Dec; 12(12):1013-22. PubMed ID: 21170265
[TBL] [Abstract][Full Text] [Related]
3. β-catenin knockdown promotes NHERF1-mediated survival of colorectal cancer cells: implications for a double-targeted therapy.
Saponaro C; Sergio S; Coluccia A; De Luca M; La Regina G; Mologni L; Famiglini V; Naccarato V; Bonetti D; Gautier C; Gianni S; Vergara D; Salzet M; Fournier I; Bucci C; Silvestri R; Passerini CG; Maffia M; Coluccia AML
Oncogene; 2018 Jun; 37(24):3301-3316. PubMed ID: 29551770
[TBL] [Abstract][Full Text] [Related]
4. NHERF1/EBP50 Suppresses Wnt-β-Catenin Pathway-Driven Intestinal Neoplasia.
Georgescu MM; Gagea M; Cote G
Neoplasia; 2016 Aug; 18(8):512-23. PubMed ID: 27566107
[TBL] [Abstract][Full Text] [Related]
5. Involvement of nuclear NHERF1 in colorectal cancer progression.
Mangia A; Saponaro C; Malfettone A; Bisceglie D; Bellizzi A; Asselti M; Popescu O; Reshkin SJ; Paradiso A; Simone G
Oncol Rep; 2012 Sep; 28(3):889-94. PubMed ID: 22766563
[TBL] [Abstract][Full Text] [Related]
6. β-catenin and K-ras mutations and RASSF1A promoter methylation in Taiwanese colorectal cancer patients.
Chen SP; Wu CC; Huang SY; Kang JC; Chiu SC; Yang KL; Pang CY
Genet Test Mol Biomarkers; 2012 Nov; 16(11):1277-81. PubMed ID: 23009572
[TBL] [Abstract][Full Text] [Related]
7. NHERF1 regulates the progression of colorectal cancer through the interplay with VEGFR2 pathway.
Gu Y; Yu H; Hao C; Martin TA; Hargest R; He J; Cheng S; Jiang WG
Oncotarget; 2017 Jan; 8(5):7753-7765. PubMed ID: 27999191
[TBL] [Abstract][Full Text] [Related]
8. WNT5A exhibits tumor-suppressive activity through antagonizing the Wnt/beta-catenin signaling, and is frequently methylated in colorectal cancer.
Ying J; Li H; Yu J; Ng KM; Poon FF; Wong SC; Chan AT; Sung JJ; Tao Q
Clin Cancer Res; 2008 Jan; 14(1):55-61. PubMed ID: 18172252
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of nuclear NHERF1 in advanced colorectal cancer: association with hypoxic microenvironment and tumor invasive phenotype.
Malfettone A; Silvestris N; Paradiso A; Mattioli E; Simone G; Mangia A
Exp Mol Pathol; 2012 Jun; 92(3):296-303. PubMed ID: 22440733
[TBL] [Abstract][Full Text] [Related]
10. [Methylation status of PCDH10 and RASSF1A gene promoters in colorectal cancer].
Li M; Yan DG; Liu JL
Zhonghua Yi Xue Za Zhi; 2016 Feb; 96(6):456-9. PubMed ID: 26875923
[TBL] [Abstract][Full Text] [Related]
11. NHERF1 inhibits beta-catenin-mediated proliferation of cervical cancer cells through suppression of alpha-actinin-4 expression.
Wang Q; Qin Q; Song R; Zhao C; Liu H; Yang Y; Gu S; Zhou D; He J
Cell Death Dis; 2018 Jun; 9(6):668. PubMed ID: 29867145
[TBL] [Abstract][Full Text] [Related]
12. Expression of trefoil factors and TWIST1 in colorectal cancer and their correlation with metastatic potential and prognosis.
Yusup A; Huji B; Fang C; Wang F; Dadihan T; Wang HJ; Upur H
World J Gastroenterol; 2017 Jan; 23(1):110-120. PubMed ID: 28104986
[TBL] [Abstract][Full Text] [Related]
13. Prognostic and therapeutic implications of NHERF1 expression and regulation in colorectal cancer.
Leiphrakpam PD; Lazenby AJ; Chowdhury S; Smith LM; Mathiesen M; Brattain MG; Wang J; Black JD; Are C
J Surg Oncol; 2020 Mar; 121(3):547-560. PubMed ID: 31867736
[TBL] [Abstract][Full Text] [Related]
14. The prognostic value of the Na⁺/ H⁺ exchanger regulatory factor 1 (NHERF1) protein in cancer.
Saponaro C; Malfettone A; Dell'Endice TS; Brunetti AE; Achimas-Cadariu P; Paradiso A; Mangia A
Cancer Biomark; 2014; 14(2-3):177-84. PubMed ID: 24878819
[TBL] [Abstract][Full Text] [Related]
15. The influence of metastatic site on the expression of CEA and cellular localization of β-catenin in colorectal cancer.
Rao US; Hoerster NS; Thirumala S; Rao PS
J Gastroenterol Hepatol; 2013 Mar; 28(3):505-12. PubMed ID: 23216017
[TBL] [Abstract][Full Text] [Related]
16. Positive feedback loop of hepatoma-derived growth factor and β-catenin promotes carcinogenesis of colorectal cancer.
Lian J; Tang J; Shi H; Li H; Zhen T; Xie W; Zhang F; Yang Y; Han A
Oncotarget; 2015 Oct; 6(30):29357-74. PubMed ID: 26296979
[TBL] [Abstract][Full Text] [Related]
17. NHERF1 and tumor microenvironment: a new scene in invasive breast carcinoma.
Saponaro C; Vagheggini A; Scarpi E; Centonze M; Catacchio I; Popescu O; Pastena MI; Giotta F; Silvestris N; Mangia A
J Exp Clin Cancer Res; 2018 May; 37(1):96. PubMed ID: 29716631
[TBL] [Abstract][Full Text] [Related]
18. β-catenin inhibits promyelocytic leukemia protein tumor suppressor function in colorectal cancer cells.
Satow R; Shitashige M; Jigami T; Fukami K; Honda K; Kitabayashi I; Yamada T
Gastroenterology; 2012 Mar; 142(3):572-81. PubMed ID: 22155184
[TBL] [Abstract][Full Text] [Related]
19. Association of DNA methylation and epigenetic inactivation of RASSF1A and beta-catenin with metastasis in small bowel carcinoid tumors.
Zhang HY; Rumilla KM; Jin L; Nakamura N; Stilling GA; Ruebel KH; Hobday TJ; Erlichman C; Erickson LA; Lloyd RV
Endocrine; 2006 Dec; 30(3):299-306. PubMed ID: 17526942
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of RASSF1A hypermethylation in colorectal cancer: a meta-analysis.
Hu H; Zhou C; Li B; Chen Y; Dai J; Mao Y; Huang T; Yu H; Chen M; Zhao J; Duan S
Pathol Res Pract; 2018 Oct; 214(10):1572-1578. PubMed ID: 30082160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
